Oncology

Researchers seek to determine how compound from chili peppers kills prostate cancer cells.

Study finds patients with low-risk prostate cancers be monitored in an active surveillance program.

Top developments from the last week in cancer treatment.

Researchers evaluate how DNA viruses work and how they can be stopped.

Findings could boost the efficacy of immunotherapy drugs.

New approach may combine with existing medications to improve survival.

Test may identify and treat premalignant pancreatic lesions.

Investigational drugs developed across specific types of lung, bladder, and skin cancers.

Alectinib is an oral anaplastic lymphoma kinase inhibitor for locally advanced or metastatic non-small cell lung cancer.

Researchers examine how a cell distinguishes between damaged DNA and foreign viral DNA.

Pharmacists can manage medications and long-term toxicities to enhance the spectrum of care.

Decrease found in chemotherapy use among patients with high-risk cancer and those who received genetic testing.

Researchers seek drug targets superior to nonsteroidal anti-inflammatory drugs.

Desire for future fertility has a negative impact on adherence to tamoxifen regimen.

Black women diagnosed with breast cancer at or below age 50 have a much higher instance of BRCA mutation.

Genetic profiling after initial chemotherapy may help oncologists predict early prognosis.

As pediatric survival rates improve, long-term problems arise from other factors.

Vaccine primes immune cells to attack patient-specific tumor tissue.

Class of receptors may be precisely targeted by drug compounds.

The latest news in oncology treatment research.

Some complementary or alternative medications can have an adverse reaction mixed with cancer drugs.

Biologic therapy targets genetic defects found in various cancers.

Baked potato extract found to suppress the spread of colon cancer stem cells.

Study shows nitroglycerin may improve the delivery of anticancer drugs.

Obesity leads to biomechanical changes that create the right conditions for tumor growth.

Varubi prevents nausea and vomiting associated with vomit-inducing cancer chemotherapy.

Cancer therapy filgrastim-sndz (Zarxio) was initially approved on March 6, 2015.

Oncologists will now be able to measure progress in cancer treatments.

Addition of docetaxel had the greatest benefit in patients with a high burden of metastatic disease.

The first biosimilar to receive FDA approval is now available the United States.